214 related articles for article (PubMed ID: 21778756)
1. Growth hormone in sports: detecting the doped or duped.
Ho KK; Nelson AE
Horm Res Paediatr; 2011; 76 Suppl 1():84-90. PubMed ID: 21778756
[TBL] [Abstract][Full Text] [Related]
2. A robust test for growth hormone doping--present status and future prospects.
Nelson AE; Ho KK
Asian J Androl; 2008 May; 10(3):416-25. PubMed ID: 18385903
[TBL] [Abstract][Full Text] [Related]
3. New detection methods of growth hormone and growth factors.
Bidlingmaier M
Endocr Dev; 2012; 23():52-9. PubMed ID: 23182820
[TBL] [Abstract][Full Text] [Related]
4. Demographic factors influencing the GH system: Implications for the detection of GH doping in sport.
Nelson AE; Ho KK
Growth Horm IGF Res; 2009 Aug; 19(4):327-32. PubMed ID: 19481485
[TBL] [Abstract][Full Text] [Related]
5. Longitudinally monitoring of P-III-NP, IGF-I, and GH-2000 score increases the probability of detecting two weeks' administration of low-dose recombinant growth hormone compared to GH-2000 decision limit and GH isoform test and micro RNA markers.
Lehtihet M; Bhuiyan H; Dalby A; Ericsson M; Ekström L
Drug Test Anal; 2019 Mar; 11(3):411-421. PubMed ID: 30223291
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone doping in sports: a critical review of use and detection strategies.
Baumann GP
Endocr Rev; 2012 Apr; 33(2):155-86. PubMed ID: 22368183
[TBL] [Abstract][Full Text] [Related]
7. The use of growth hormone (GH)-dependent markers in the detection of GH abuse in sport: Physiological intra-individual variation of IGF-I, type 3 pro-collagen (P-III-P) and the GH-2000 detection score.
Erotokritou-Mulligan I; Eryl Bassett E; Cowan DA; Bartlett C; Milward P; Sartorio A; Sönksen PH; Holt RI
Clin Endocrinol (Oxf); 2010 Apr; 72(4):520-6. PubMed ID: 19650783
[TBL] [Abstract][Full Text] [Related]
8. Detecting growth hormone abuse in athletes.
Holt RI
Drug Test Anal; 2009 Sep; 1(9-10):426-33. PubMed ID: 20355225
[TBL] [Abstract][Full Text] [Related]
9. Detecting growth hormone abuse in athletes.
Bidlingmaier M; Manolopoulou J
Endocrinol Metab Clin North Am; 2010 Mar; 39(1):25-32, vii. PubMed ID: 20122447
[TBL] [Abstract][Full Text] [Related]
10. Biomarker detection of rhGH doping: an excretion study.
Jing J; Zhou X; He C; Zhang L; Yang S; Xu Y; Xie M; Yan Y; Su H; Wu M
Drug Test Anal; 2012 Oct; 4(10):739-44. PubMed ID: 23074170
[TBL] [Abstract][Full Text] [Related]
11. Moving one step closer to catching the GH cheats: The GH-2004 experience.
Holt RI; Bassett EE; Erotokritou-Mulligan I; McHugh C; Cowan D; Bartlett C; Sönksen PH;
Growth Horm IGF Res; 2009 Aug; 19(4):346-51. PubMed ID: 19467613
[TBL] [Abstract][Full Text] [Related]
12. Insulin, growth hormone and sport.
Sonksen PH
J Endocrinol; 2001 Jul; 170(1):13-25. PubMed ID: 11431133
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of GH isoform differential immunoassay for detecting rhGH doping on application of various growth factors.
Okano M; Nishitani Y; Sato M; Kageyama S
Drug Test Anal; 2012 Sep; 4(9):692-700. PubMed ID: 22733714
[TBL] [Abstract][Full Text] [Related]
14. The development of decision limits for the GH-2000 detection methodology using additional insulin-like growth factor-I and amino-terminal pro-peptide of type III collagen assays.
Holt RI; Böhning W; Guha N; Bartlett C; Cowan DA; Giraud S; Bassett EE; Sönksen PH; Böhning D
Drug Test Anal; 2015 Sep; 7(9):745-55. PubMed ID: 25645199
[TBL] [Abstract][Full Text] [Related]
15. The development of decision limits for the implementation of the GH-2000 detection methodology using current commercial insulin-like growth factor-I and amino-terminal pro-peptide of type III collagen assays.
Erotokritou-Mulligan I; Guha N; Stow M; Bassett EE; Bartlett C; Cowan DA; Sönksen PH; Holt RI
Growth Horm IGF Res; 2012 Apr; 22(2):53-8. PubMed ID: 22305721
[TBL] [Abstract][Full Text] [Related]
16. Intra-individual variation of GH-dependent markers in athletes: comparison of population based and individual thresholds for detection of GH abuse in sports.
Kniess A; Ziegler E; Thieme D; Müller RK
J Pharm Biomed Anal; 2013 Oct; 84():201-8. PubMed ID: 23850935
[TBL] [Abstract][Full Text] [Related]
17. Detecting growth hormone abuse in athletes.
Holt RI
Anal Bioanal Chem; 2011 Aug; 401(2):449-62. PubMed ID: 21590497
[TBL] [Abstract][Full Text] [Related]
18. Serum insulin-like growth factor-I and pro-collagen type III N-terminal peptide in adolescent elite athletes: implications for the detection of growth hormone abuse in sport.
Guha N; Erotokritou-Mulligan I; Burford C; Strobridge G; Brigg J; Drake T; Bassett EE; Cowan D; Bartlett C; Sönksen PH; Holt RI
J Clin Endocrinol Metab; 2010 Jun; 95(6):2969-76. PubMed ID: 20410221
[TBL] [Abstract][Full Text] [Related]
19. Genetic and protein biomarkers in blood for the improved detection of GH abuse.
Ferro P; Ventura R; Pérez-Mañá C; Farré M; Segura J
J Pharm Biomed Anal; 2016 Sep; 128():111-118. PubMed ID: 27243825
[TBL] [Abstract][Full Text] [Related]
20. Combined evaluation of resting IGF1, N-terminal propeptide of type III procollagen and C-terminal cross-linked telopeptide of type I collagen levels might be useful for detecting inappropriate GH administration in female athletes.
Di Luigi L; Rigamonti AE; Agosti F; Mencarelli M; Sgrò P; Marazzi N; Cella SG; Müller EE; Sartorio A
Eur J Endocrinol; 2009 May; 160(5):753-8. PubMed ID: 19258430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
